<PAGE>
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 5, 1997
ROBERTS PHARMACEUTICAL CORPORATION
- --------------------------------------------------------------------------------
(exact name of registrant as specified in its charter)
New Jersey 1-1-432 22-2429994
- ----------------- --------------- -------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
- --------------------------------------------------------------------------------
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code: 908-389-1182
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
- --------------------------------------------------------------------------------
(Former name or former address, if changed from last report)
<PAGE>
-2-
Item 5. Other Events
------------
Roberts Pharmaceutical Corporation announced today that Louis P.
Berardi, formerly of Hoechst Marion Roussel, has joined Roberts as Senior Vice
President, New Business Development and Strategic Planning.
Mr. Berardi, with over 20 years experience in new business development
and strategic planning in both the national and international arenas, previously
held senior positions with SmithKline Beecham, PLC, Carter-Wallace, Inc., and
most recently with Hoechst Marion Roussel. Mr. Berardi received his Bachelor of
Arts and an MBA in Finance and Economics from Fairleigh Dickinson University.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ROBERTS PHARMACEUTICAL CORPORATION
----------------------------------
(Registrant)
Date: November 6, 1997 By: /s/ John T. Spitznagel
-------------------------------
John T. Spitznagel
President and C.E.O.
